Matches in Nanopublications for { ?s ?p "[These findings provide further support that ALK-positive ALCL is a distinct pathologic entity among pediatric large cell lymphomas primarily characterized by expression of T-cell markers, CD30, and EMA, and by a younger mean age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[These findings provide further support that ALK-positive ALCL is a distinct pathologic entity among pediatric large cell lymphomas primarily characterized by expression of T-cell markers, CD30, and EMA, and by a younger mean age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP307279.RAUKZvfChNRD8B93YKChfS0l3flVBHNmFVJVhH2ZFn9S4130_assertion description "[These findings provide further support that ALK-positive ALCL is a distinct pathologic entity among pediatric large cell lymphomas primarily characterized by expression of T-cell markers, CD30, and EMA, and by a younger mean age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307279.RAUKZvfChNRD8B93YKChfS0l3flVBHNmFVJVhH2ZFn9S4130_provenance.
- NP307280.RAuEH2s95zjNmmoEG9cgZt0NeSoLy8B37Rw1rgcXoVBiw130_assertion description "[These findings provide further support that ALK-positive ALCL is a distinct pathologic entity among pediatric large cell lymphomas primarily characterized by expression of T-cell markers, CD30, and EMA, and by a younger mean age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307280.RAuEH2s95zjNmmoEG9cgZt0NeSoLy8B37Rw1rgcXoVBiw130_provenance.